StockComparison Logo
vs

ABUS vs RZLV

Comparison between Arbutus Biopharma Corp (ABUS, Company) and Rezolve AI Ltd (RZLV, Company).

ABUS is from the Healthcare sector, while RZLV is from the Technology sector.

ABUS vs RZLV - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
ABUS
$898M
RZLV
$803M
Max Drawdown
ABUS
92.96%
Winner
RZLV
89.04%
Sharpe Ratio
Winner
ABUS
0.89
RZLV
0.49
5Y Beta
Winner
ABUS
0.89
RZLV
2.05
Industry
ABUS
Biotechnology
RZLV
Software - Infrastructure
P/E Ratio
ABUS
5.60
Winner
RZLV
-3.85
Forward P/E
ABUS
10.25
RZLV
N/A
Debt to Equity
Winner
ABUS
0.00%
RZLV
63.72%
Free Cash Flow Yield
Winner
ABUS
-3.83%
RZLV
-4.76%

ABUS vs RZLV - Historical Returns

Returns include dividend reinvestment.

1M
Winner
ABUS
+7.97%
RZLV
-9.54%
3M
Winner
ABUS
+1.28%
RZLV
-12.87%
6M
Winner
ABUS
+16.75%
RZLV
-48.59%
1Y
Winner
ABUS
+51.44%
RZLV
-10.57%
5Y(CAGR)
ABUS
+12.25%
RZLV
N/A
10Y(CAGR)
ABUS
+1.19%
RZLV
N/A
Max(CAGR)
Winner
ABUS
-7.00%
RZLV
-53.33%

ABUS vs RZLV - Annual Returns (2015 - 2026)

Returns include dividend reinvestment.

YearABUSRZLV
2026-0.63%-17.42%
2025+46.20%-37.16%
2024+26.25%-62.51%
2023+12.11%N/A
2022-41.46%N/A
2021+6.87%N/A
2020+20.75%N/A
2019-30.50%N/A
2018-29.72%N/A
2017+102.00%N/A
2016-45.80%N/A
2015-57.62%N/A

ABUS vs RZLV Drawdown Comparison

The maximum drawdown for ABUS was -92.96%, occurring on Oct 9, 2019. This drawdown has not yet recovered.

The maximum drawdown for RZLV was -89.04%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The current ABUS drawdown is -61.62%. The current RZLV drawdown is -77.01%.

RankABUSRZLV
#1-92.96%
Aug 2, 2018 - Oct 9, 2019
-89.04%
Aug 22, 2024 - Apr 8, 2025
#2-76.67%
Aug 3, 2015 - Jul 11, 2018
-21.00%
Aug 16, 2024 - Aug 22, 2024
#3-8.12%
Jul 13, 2018 - Aug 1, 2018
N/A

Correlation

Correlation between ABUS and RZLV is 0.07 which considered as a very weak or no correlation - the stocks move independently of each other.

0.07
-101

Select Stocks to Compare